General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v3.24.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flow from Operating Activities:        
Net loss available to common stockholders $ (2,830) $ (3,484) $ (22,770) $ (39,316)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 35 424 1,678 1,690
Amortization of debt issuance costs and discounts 20 19 193 56
Goodwill impairment     18,614
Intangible asset impairment     8,532
Share-based compensation 518 861 1,773 2,969
Change in fair value of warrant liabilities     236
Amortization of prepaid assets     2,095
Accreted interest expense on term loan 153 291
Inventory reserve (123) (682) (474) 1,809
Loss of disposal of assets 11 11
PIK interest expense on term loan 125 254
Income tax provision     (2)
Other 49 4 126
Changes in operating assets and liabilities:        
Accounts receivable 24 427 2,387 (66)
Inventories 1,533 2,056 4,120 (6,821)
Prepaid expenses and other assets (355) (230) 628 (1,047)
Accounts payable 550 196 3,996 (761)
Accrued and other liabilities (705) (1,071) (760) 99
Cash Provided by (Used in) Operating Activities (1,006) (1,473) 97 (20,553)
Cash Flow from Investing Activities:        
Capital expenditures (3) (10) (18) (198)
Cash Used in Investing Activities (3) (10) (18) (198)
Cash Flow from Financing Activities:        
Payments on short-term financing arrangement     (248)
Proceeds from revolving lines of credit     1,906 12,317
Payments on revolving lines of credit     (13,500) (5,640)
Proceeds from line of credit     7,841
Payments on line of credit     (6,100)
Proceeds from term loan     5,000
Payments on term loans     (5,450)
Payment of loan issuance costs     (244) (110)
Proceeds from Wintrust Facility 3,010    
Payments on Wintrust Facility (2,580)    
Proceeds from short-term financing arrangement (41) 413
Cash (Used in) Provided by Financing Activities 430 (41) (5,097) 1,282
Net decrease in cash and cash equivalents and restricted cash (579) (1,524) (5,018) (19,469)
Total cash and cash equivalents and restricted cash, beginning of period 4,455 9,473 9,473 28,942
Total cash and cash equivalents and restricted cash, end of period 3,876 7,949 4,455 9,473
Cash paid during the year for:        
Income taxes     12
Interest 64 237 543 444
Noncash items:        
Aimia acquisition $ 400    
Reclassification of warrants to equity     $ 2,444